The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2024 to US$ 7419.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.

Parkinsons Disease Drug Market

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Parkinsons Disease Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Parkinsons Disease Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Parkinsons Disease Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parkinsons Disease Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Parkinsons Disease Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Parkinsons Disease Drug sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Parkinsons Disease Drug Market Report

Report Metric	Details
Report Name	Parkinsons Disease Drug Market
Accounted market size in 2024	US$ 5763.6 million
Forecasted market size in 2030	US$ 7419.9 million
CAGR	4.3
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Carbidopa/Levodopa Dopamine Receptor Agonists MAO-Inhibitors
Segment by Application	Hospital Clinics Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, Sun Pharma, Wockhardt, UCB, Bausch Health, Acadia
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Parkinsons Disease Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Parkinsons Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parkinsons Disease Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Parkinsons Disease Drug Market growing?

Ans: The Parkinsons Disease Drug Market witnessing a CAGR of 4.3 during the forecast period 2025-2030.

What is the Parkinsons Disease Drug Market size in 2030?

Ans: The Parkinsons Disease Drug Market size in 2030 will be US$ 7419.9 million.

Who are the main players in the Parkinsons Disease Drug Market report?

Ans: The main players in the Parkinsons Disease Drug Market are GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, Sun Pharma, Wockhardt, UCB, Bausch Health, Acadia

What are the Application segmentation covered in the Parkinsons Disease Drug Market report?

Ans: The Applications covered in the Parkinsons Disease Drug Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Parkinsons Disease Drug Market report?

Ans: The Types covered in the Parkinsons Disease Drug Market report are Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors

1 Study Coverage

1.1 Parkinsons Disease Drug Product Introduction

1.2 Market by Type

1.2.1 Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Carbidopa/Levodopa

1.2.3 Dopamine Receptor Agonists

1.2.4 MAO-Inhibitors

1.3 Market by Application

1.3.1 Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Parkinsons Disease Drug Sales Estimates and Forecasts 2019-2030

2.2 Global Parkinsons Disease Drug Revenue by Region

2.2.1 Global Parkinsons Disease Drug Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Parkinsons Disease Drug Revenue by Region (2019-2024)

2.2.3 Global Parkinsons Disease Drug Revenue by Region (2025-2030)

2.2.4 Global Parkinsons Disease Drug Revenue Market Share by Region (2019-2030)

2.3 Global Parkinsons Disease Drug Sales Estimates and Forecasts 2019-2030

2.4 Global Parkinsons Disease Drug Sales by Region

2.4.1 Global Parkinsons Disease Drug Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Parkinsons Disease Drug Sales by Region (2019-2024)

2.4.3 Global Parkinsons Disease Drug Sales by Region (2025-2030)

2.4.4 Global Parkinsons Disease Drug Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Parkinsons Disease Drug Sales by Manufacturers

3.1.1 Global Parkinsons Disease Drug Sales by Manufacturers (2019-2024)

3.1.2 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parkinsons Disease Drug in 2023

3.2 Global Parkinsons Disease Drug Revenue by Manufacturers

3.2.1 Global Parkinsons Disease Drug Revenue by Manufacturers (2019-2024)

3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Parkinsons Disease Drug Revenue in 2023

3.3 Global Key Players of Parkinsons Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Parkinsons Disease Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Parkinsons Disease Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Parkinsons Disease Drug, Product Offered and Application

3.8 Global Key Manufacturers of Parkinsons Disease Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Parkinsons Disease Drug Sales by Type

4.1.1 Global Parkinsons Disease Drug Historical Sales by Type (2019-2024)

4.1.2 Global Parkinsons Disease Drug Forecasted Sales by Type (2025-2030)

4.1.3 Global Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

4.2 Global Parkinsons Disease Drug Revenue by Type

4.2.1 Global Parkinsons Disease Drug Historical Revenue by Type (2019-2024)

4.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Type (2025-2030)

4.2.3 Global Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

4.3 Global Parkinsons Disease Drug Price by Type

4.3.1 Global Parkinsons Disease Drug Price by Type (2019-2024)

4.3.2 Global Parkinsons Disease Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Parkinsons Disease Drug Sales by Application

5.1.1 Global Parkinsons Disease Drug Historical Sales by Application (2019-2024)

5.1.2 Global Parkinsons Disease Drug Forecasted Sales by Application (2025-2030)

5.1.3 Global Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

5.2 Global Parkinsons Disease Drug Revenue by Application

5.2.1 Global Parkinsons Disease Drug Historical Revenue by Application (2019-2024)

5.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Application (2025-2030)

5.2.3 Global Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

5.3 Global Parkinsons Disease Drug Price by Application

5.3.1 Global Parkinsons Disease Drug Price by Application (2019-2024)

5.3.2 Global Parkinsons Disease Drug Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Parkinsons Disease Drug Market Size by Type

6.1.1 US & Canada Parkinsons Disease Drug Sales by Type (2019-2030)

6.1.2 US & Canada Parkinsons Disease Drug Revenue by Type (2019-2030)

6.2 US & Canada Parkinsons Disease Drug Market Size by Application

6.2.1 US & Canada Parkinsons Disease Drug Sales by Application (2019-2030)

6.2.2 US & Canada Parkinsons Disease Drug Revenue by Application (2019-2030)

6.3 US & Canada Parkinsons Disease Drug Market Size by Country

6.3.1 US & Canada Parkinsons Disease Drug Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Parkinsons Disease Drug Sales by Country (2019-2030)

6.3.3 US & Canada Parkinsons Disease Drug Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Parkinsons Disease Drug Market Size by Type

7.1.1 Europe Parkinsons Disease Drug Sales by Type (2019-2030)

7.1.2 Europe Parkinsons Disease Drug Revenue by Type (2019-2030)

7.2 Europe Parkinsons Disease Drug Market Size by Application

7.2.1 Europe Parkinsons Disease Drug Sales by Application (2019-2030)

7.2.2 Europe Parkinsons Disease Drug Revenue by Application (2019-2030)

7.3 Europe Parkinsons Disease Drug Market Size by Country

7.3.1 Europe Parkinsons Disease Drug Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Parkinsons Disease Drug Sales by Country (2019-2030)

7.3.3 Europe Parkinsons Disease Drug Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Parkinsons Disease Drug Market Size

8.1.1 China Parkinsons Disease Drug Sales (2019-2030)

8.1.2 China Parkinsons Disease Drug Revenue (2019-2030)

8.2 China Parkinsons Disease Drug Market Size by Application

8.2.1 China Parkinsons Disease Drug Sales by Application (2019-2030)

8.2.2 China Parkinsons Disease Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Parkinsons Disease Drug Market Size by Type

9.1.1 Asia Parkinsons Disease Drug Sales by Type (2019-2030)

9.1.2 Asia Parkinsons Disease Drug Revenue by Type (2019-2030)

9.2 Asia Parkinsons Disease Drug Market Size by Application

9.2.1 Asia Parkinsons Disease Drug Sales by Application (2019-2030)

9.2.2 Asia Parkinsons Disease Drug Revenue by Application (2019-2030)

9.3 Asia Parkinsons Disease Drug Sales by Region

9.3.1 Asia Parkinsons Disease Drug Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Parkinsons Disease Drug Revenue by Region (2019-2030)

9.3.3 Asia Parkinsons Disease Drug Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Parkinsons Disease Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Parkinsons Disease Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Teva

11.1.1 Teva Company Information

11.1.2 Teva Overview

11.1.3 Teva Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Teva Recent Developments

11.2 Novartis AG

11.2.1 Novartis AG Company Information

11.2.2 Novartis AG Overview

11.2.3 Novartis AG Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novartis AG Recent Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Overview

11.3.3 GSK Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GSK Recent Developments

11.4 AbbVie

11.4.1 AbbVie Company Information

11.4.2 AbbVie Overview

11.4.3 AbbVie Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 AbbVie Recent Developments

11.5 Merck

11.5.1 Merck Company Information

11.5.2 Merck Overview

11.5.3 Merck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merck Recent Developments

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Information

11.6.2 Boehringer Ingelheim Overview

11.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Boehringer Ingelheim Recent Developments

11.7 Impax Laboratories

11.7.1 Impax Laboratories Company Information

11.7.2 Impax Laboratories Overview

11.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Impax Laboratories Recent Developments

11.8 Lundbeck

11.8.1 Lundbeck Company Information

11.8.2 Lundbeck Overview

11.8.3 Lundbeck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Lundbeck Recent Developments

11.9 Sun Pharma

11.9.1 Sun Pharma Company Information

11.9.2 Sun Pharma Overview

11.9.3 Sun Pharma Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Sun Pharma Recent Developments

11.10 Wockhardt

11.10.1 Wockhardt Company Information

11.10.2 Wockhardt Overview

11.10.3 Wockhardt Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Wockhardt Recent Developments

11.11 UCB

11.11.1 UCB Company Information

11.11.2 UCB Overview

11.11.3 UCB Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 UCB Recent Developments

11.12 Bausch Health

11.12.1 Bausch Health Company Information

11.12.2 Bausch Health Overview

11.12.3 Bausch Health Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Bausch Health Recent Developments

11.13 Acadia

11.13.1 Acadia Company Information

11.13.2 Acadia Overview

11.13.3 Acadia Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Acadia Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Parkinsons Disease Drug Industry Chain Analysis

12.2 Parkinsons Disease Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Parkinsons Disease Drug Production Mode & Process

12.4 Parkinsons Disease Drug Sales and Marketing

12.4.1 Parkinsons Disease Drug Sales Channels

12.4.2 Parkinsons Disease Drug Distributors

12.5 Parkinsons Disease Drug Customers

13 Market Dynamics

13.1 Parkinsons Disease Drug Industry Trends

13.2 Parkinsons Disease Drug Market Drivers

13.3 Parkinsons Disease Drug Market Challenges

13.4 Parkinsons Disease Drug Market Restraints

14 Key Findings in The Global Parkinsons Disease Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Carbidopa/Levodopa

Table 3. Major Manufacturers of Dopamine Receptor Agonists

Table 4. Major Manufacturers of MAO-Inhibitors

Table 5. Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Parkinsons Disease Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Parkinsons Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Parkinsons Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Parkinsons Disease Drug Revenue Market Share by Region (2019-2024)

Table 10. Global Parkinsons Disease Drug Revenue Market Share by Region (2025-2030)

Table 11. Global Parkinsons Disease Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Parkinsons Disease Drug Sales by Region (2019-2024) & (K Doses)

Table 13. Global Parkinsons Disease Drug Sales by Region (2025-2030) & (K Doses)

Table 14. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2024)

Table 15. Global Parkinsons Disease Drug Sales Market Share by Region (2025-2030)

Table 16. Global Parkinsons Disease Drug Sales by Manufacturers (2019-2024) & (K Doses)

Table 17. Global Parkinsons Disease Drug Sales Share by Manufacturers (2019-2024)

Table 18. Global Parkinsons Disease Drug Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Parkinsons Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Parkinsons Disease Drug Price by Manufacturers 2019-2024 (USD/Dose)

Table 22. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Parkinsons Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2023)

Table 24. Global Key Manufacturers of Parkinsons Disease Drug, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Parkinsons Disease Drug, Product Offered and Application

Table 26. Global Key Manufacturers of Parkinsons Disease Drug, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Parkinsons Disease Drug Sales by Type (2019-2024) & (K Doses)

Table 29. Global Parkinsons Disease Drug Sales by Type (2025-2030) & (K Doses)

Table 30. Global Parkinsons Disease Drug Sales Share by Type (2019-2024)

Table 31. Global Parkinsons Disease Drug Sales Share by Type (2025-2030)

Table 32. Global Parkinsons Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Parkinsons Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Parkinsons Disease Drug Revenue Share by Type (2019-2024)

Table 35. Global Parkinsons Disease Drug Revenue Share by Type (2025-2030)

Table 36. Parkinsons Disease Drug Price by Type (2019-2024) & (USD/Dose)

Table 37. Global Parkinsons Disease Drug Price Forecast by Type (2025-2030) & (USD/Dose)

Table 38. Global Parkinsons Disease Drug Sales by Application (2019-2024) & (K Doses)

Table 39. Global Parkinsons Disease Drug Sales by Application (2025-2030) & (K Doses)

Table 40. Global Parkinsons Disease Drug Sales Share by Application (2019-2024)

Table 41. Global Parkinsons Disease Drug Sales Share by Application (2025-2030)

Table 42. Global Parkinsons Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Parkinsons Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Parkinsons Disease Drug Revenue Share by Application (2019-2024)

Table 45. Global Parkinsons Disease Drug Revenue Share by Application (2025-2030)

Table 46. Parkinsons Disease Drug Price by Application (2019-2024) & (USD/Dose)

Table 47. Global Parkinsons Disease Drug Price Forecast by Application (2025-2030) & (USD/Dose)

Table 48. US & Canada Parkinsons Disease Drug Sales by Type (2019-2024) & (K Doses)

Table 49. US & Canada Parkinsons Disease Drug Sales by Type (2025-2030) & (K Doses)

Table 50. US & Canada Parkinsons Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Parkinsons Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Parkinsons Disease Drug Sales by Application (2019-2024) & (K Doses)

Table 53. US & Canada Parkinsons Disease Drug Sales by Application (2025-2030) & (K Doses)

Table 54. US & Canada Parkinsons Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Parkinsons Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Parkinsons Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Parkinsons Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Parkinsons Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Parkinsons Disease Drug Sales by Country (2019-2024) & (K Doses)

Table 60. US & Canada Parkinsons Disease Drug Sales by Country (2025-2030) & (K Doses)

Table 61. Europe Parkinsons Disease Drug Sales by Type (2019-2024) & (K Doses)

Table 62. Europe Parkinsons Disease Drug Sales by Type (2025-2030) & (K Doses)

Table 63. Europe Parkinsons Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Parkinsons Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Parkinsons Disease Drug Sales by Application (2019-2024) & (K Doses)

Table 66. Europe Parkinsons Disease Drug Sales by Application (2025-2030) & (K Doses)

Table 67. Europe Parkinsons Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Parkinsons Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Parkinsons Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Parkinsons Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Parkinsons Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Parkinsons Disease Drug Sales by Country (2019-2024) & (K Doses)

Table 73. Europe Parkinsons Disease Drug Sales by Country (2025-2030) & (K Doses)

Table 74. China Parkinsons Disease Drug Sales by Type (2019-2024) & (K Doses)

Table 75. China Parkinsons Disease Drug Sales by Type (2025-2030) & (K Doses)

Table 76. China Parkinsons Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Parkinsons Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Parkinsons Disease Drug Sales by Application (2019-2024) & (K Doses)

Table 79. China Parkinsons Disease Drug Sales by Application (2025-2030) & (K Doses)

Table 80. China Parkinsons Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Parkinsons Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Parkinsons Disease Drug Sales by Type (2019-2024) & (K Doses)

Table 83. Asia Parkinsons Disease Drug Sales by Type (2025-2030) & (K Doses)

Table 84. Asia Parkinsons Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Parkinsons Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Parkinsons Disease Drug Sales by Application (2019-2024) & (K Doses)

Table 87. Asia Parkinsons Disease Drug Sales by Application (2025-2030) & (K Doses)

Table 88. Asia Parkinsons Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Parkinsons Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Parkinsons Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Parkinsons Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Parkinsons Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Parkinsons Disease Drug Sales by Region (2019-2024) & (K Doses)

Table 94. Asia Parkinsons Disease Drug Sales by Region (2025-2030) & (K Doses)

Table 95. Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Type (2019-2024) & (K Doses)

Table 96. Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Type (2025-2030) & (K Doses)

Table 97. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Application (2019-2024) & (K Doses)

Table 100. Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Application (2025-2030) & (K Doses)

Table 101. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Country (2019-2024) & (K Doses)

Table 107. Middle East, Africa and Latin America Parkinsons Disease Drug Sales by Country (2025-2030) & (K Doses)

Table 108. Teva Company Information

Table 109. Teva Description and Major Businesses

Table 110. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 111. Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Teva Recent Developments

Table 113. Novartis AG Company Information

Table 114. Novartis AG Description and Major Businesses

Table 115. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 116. Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Novartis AG Recent Developments

Table 118. GSK Company Information

Table 119. GSK Description and Major Businesses

Table 120. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 121. GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. GSK Recent Developments

Table 123. AbbVie Company Information

Table 124. AbbVie Description and Major Businesses

Table 125. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 126. AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. AbbVie Recent Developments

Table 128. Merck Company Information

Table 129. Merck Description and Major Businesses

Table 130. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 131. Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Merck Recent Developments

Table 133. Boehringer Ingelheim Company Information

Table 134. Boehringer Ingelheim Description and Major Businesses

Table 135. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 136. Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Boehringer Ingelheim Recent Developments

Table 138. Impax Laboratories Company Information

Table 139. Impax Laboratories Description and Major Businesses

Table 140. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 141. Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Impax Laboratories Recent Developments

Table 143. Lundbeck Company Information

Table 144. Lundbeck Description and Major Businesses

Table 145. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 146. Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Lundbeck Recent Developments

Table 148. Sun Pharma Company Information

Table 149. Sun Pharma Description and Major Businesses

Table 150. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 151. Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Sun Pharma Recent Developments

Table 153. Wockhardt Company Information

Table 154. Wockhardt Description and Major Businesses

Table 155. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 156. Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Wockhardt Recent Developments

Table 158. UCB Company Information

Table 159. UCB Description and Major Businesses

Table 160. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 161. UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. UCB Recent Developments

Table 163. Bausch Health Company Information

Table 164. Bausch Health Description and Major Businesses

Table 165. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 166. Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Bausch Health Recent Developments

Table 168. Acadia Company Information

Table 169. Acadia Description and Major Businesses

Table 170. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 171. Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 172. Acadia Recent Developments

Table 173. Key Raw Materials Lists

Table 174. Raw Materials Key Suppliers Lists

Table 175. Parkinsons Disease Drug Distributors List

Table 176. Parkinsons Disease Drug Customers List

Table 177. Parkinsons Disease Drug Market Trends

Table 178. Parkinsons Disease Drug Market Drivers

Table 179. Parkinsons Disease Drug Market Challenges

Table 180. Parkinsons Disease Drug Market Restraints

Table 181. Research Programs/Design for This Report

Table 182. Key Data Information from Secondary Sources

Table 183. Key Data Information from Primary Sources

List of Figures

Figure 1. Parkinsons Disease Drug Product Picture

Figure 2. Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Parkinsons Disease Drug Market Share by Type in 2023 & 2030

Figure 4. Carbidopa/Levodopa Product Picture

Figure 5. Dopamine Receptor Agonists Product Picture

Figure 6. MAO-Inhibitors Product Picture

Figure 7. Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Parkinsons Disease Drug Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinics

Figure 11. Other

Figure 12. Parkinsons Disease Drug Report Years Considered

Figure 13. Global Parkinsons Disease Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Parkinsons Disease Drug Revenue 2019-2030 (US$ Million)

Figure 15. Global Parkinsons Disease Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Parkinsons Disease Drug Revenue Market Share by Region (2019-2030)

Figure 17. Global Parkinsons Disease Drug Sales 2019-2030 ((K Doses)

Figure 18. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Parkinsons Disease Drug Sales YoY (2019-2030) & (K Doses)

Figure 20. US & Canada Parkinsons Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Parkinsons Disease Drug Sales YoY (2019-2030) & (K Doses)

Figure 22. Europe Parkinsons Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Parkinsons Disease Drug Sales YoY (2019-2030) & (K Doses)

Figure 24. China Parkinsons Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Parkinsons Disease Drug Sales YoY (2019-2030) & (K Doses)

Figure 26. Asia (excluding China) Parkinsons Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Parkinsons Disease Drug Sales YoY (2019-2030) & (K Doses)

Figure 28. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Parkinsons Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Parkinsons Disease Drug in the World: Market Share by Parkinsons Disease Drug Revenue in 2023

Figure 31. Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

Figure 33. Global Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

Figure 34. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

Figure 35. Global Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Parkinsons Disease Drug Revenue Share by Country (2019-2030)

Figure 41. US & Canada Parkinsons Disease Drug Sales Share by Country (2019-2030)

Figure 42. U.S. Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

Figure 45. Europe Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

Figure 46. Europe Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

Figure 47. Europe Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

Figure 48. Europe Parkinsons Disease Drug Revenue Share by Country (2019-2030)

Figure 49. Europe Parkinsons Disease Drug Sales Share by Country (2019-2030)

Figure 50. Germany Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 51. France Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 55. China Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

Figure 56. China Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

Figure 57. China Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

Figure 58. China Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

Figure 59. Asia Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

Figure 60. Asia Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

Figure 61. Asia Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

Figure 62. Asia Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

Figure 63. Asia Parkinsons Disease Drug Revenue Share by Region (2019-2030)

Figure 64. Asia Parkinsons Disease Drug Sales Share by Region (2019-2030)

Figure 65. Japan Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 69. India Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Parkinsons Disease Drug Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Parkinsons Disease Drug Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Parkinsons Disease Drug Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Parkinsons Disease Drug Sales Share by Country (2019-2030)

Figure 76. Brazil Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Parkinsons Disease Drug Revenue (2019-2030) & (US$ Million)

Figure 81. Parkinsons Disease Drug Value Chain

Figure 82. Parkinsons Disease Drug Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Parkinson Disease Drug Market Insights Forecast to 2030

Global Levodopa Tablets Market Research Report 2024

Global Parkinson s Disease Treatment Market Insights Forecast to 2030

Global Parkinson s Disease Therapeutics Market Research Report 2025

Global Levodopa Market Insights Forecast to 2030

Global Anti Parkinson Drugs Market Insights Forecast to 2030

Global Compound Levodopa Market Research Report 2025

Global Oral Medications for Parkinson s Disease Market Research Report 2024

Global Carbidopa Levodopa Tablets Market Research Report 2025

Global Anti Parkinson s Disease Drugs Market Research Report 2024

Global Anticholinergic Drugs For PD Market Research Report 2025

Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030

Global Oral Parkinson s Disease Medications Market Research Report 2024

Global Carbidopa and Levodopa Sustained release Tablets Market Research Report 2024

Global Oral Antiparkinsonian Drugs Market Research Report 2024

Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Carbidopa and Levodopa API Market Research Report 2025

Global Parkinson s Disease Monitoring Device Market Research Report 2024

Global Targeted Drugs for Parkinson s Disease Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions